Syndax Pharmaceuticals (SNDX) Debt Ratio (2020 - 2024)

Syndax Pharmaceuticals' Debt Ratio history runs 4 years deep, the most recent figure standing at 0.47 for Q4 2024.

• On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.47 in Q4 2024; TTM through Dec 2024 was 0.47, a N/A change from a year earlier, with the FY2024 full-year figure at 0.47, changed N/A from the prior year.
• Debt Ratio grew to 0.47 in Q4 2024 per SNDX's latest filing, from 0.05 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.47 in Q4 2024 and bottomed at 0.04 in Q4 2021.
• The 4-year median for Debt Ratio is 0.08 (2021), against an average of 0.12.
• Biggest YoY gain for Debt Ratio was 23.37% in 2021; the steepest drop was 61.56% in 2021.
• Year by year, Debt Ratio stood at 0.07 in 2020, then plunged by 33.89% to 0.04 in 2021, then climbed by 12.36% to 0.05 in 2022, then surged by 853.76% to 0.47 in 2024.
• Per Business Quant, the three latest SNDX Debt Ratio figures stand at 0.47 (Q4 2024), 0.05 (Q2 2022), and 0.05 (Q1 2022).